The applications which are approved on the US market are very much alive. Just not enough to sustain the company so far to get TAVR approved.
The simple reasons why Arnold Swartzenegger didn't get our TAVR when he had heart surgery might be:
- his problem wasn't a valve?
- our TAVR hasn't yet been approved by the FDA!
It's a spray up to your usual standards.
Apple indeed. TAVR is a colossal market and our valve is superior. Go figure.
Under the Radar, page-292
-
- There are more pages in this discussion • 247 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.15 |
Change
0.350(2.97%) |
Mkt cap ! $256.8M | |||
| Open | High | Low | Value | Volume |
| $11.80 | $12.15 | $11.21 | $376.0K | 32.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 139 | $12.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.15 | 830 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |